View in EDS

Virtual Bioequivalence Assessment of Long-acting Injectable Suspensions Using PBPK Modeling: Part 1. Impact of particle Size on Formulation Variability.

Saved in:
Bibliographic Details
Title: Virtual Bioequivalence Assessment of Long-acting Injectable Suspensions Using PBPK Modeling: Part 1. Impact of particle Size on Formulation Variability.
Authors: Morris NM; Certara Predictive Technologies (CPT), Certara UK, Certara UK Limited, Simcyp Division, Level 2-Acero, 1 Concourse Way, Sheffield, S1 2BJ, UK. Natalie.Morris@certara.com., Djehizian A; Certara Predictive Technologies (CPT), Certara UK, Certara UK Limited, Simcyp Division, Level 2-Acero, 1 Concourse Way, Sheffield, S1 2BJ, UK., Mittapelly N; Certara Predictive Technologies (CPT), Certara UK, Certara UK Limited, Simcyp Division, Level 2-Acero, 1 Concourse Way, Sheffield, S1 2BJ, UK., Telaprolu KC; Certara Predictive Technologies (CPT), Certara UK, Certara UK Limited, Simcyp Division, Level 2-Acero, 1 Concourse Way, Sheffield, S1 2BJ, UK., Holland BW; Certara Predictive Technologies (CPT), Certara UK, Certara UK Limited, Simcyp Division, Level 2-Acero, 1 Concourse Way, Sheffield, S1 2BJ, UK., McNally K; Certara Predictive Technologies (CPT), Certara UK, Certara UK Limited, Simcyp Division, Level 2-Acero, 1 Concourse Way, Sheffield, S1 2BJ, UK., Polak S; Certara Predictive Technologies (CPT), Certara UK, Certara UK Limited, Simcyp Division, Level 2-Acero, 1 Concourse Way, Sheffield, S1 2BJ, UK.; Jagiellonian University Medical College, Faculty of Pharmacy, Krakow, Poland., Jamei M; Certara Predictive Technologies (CPT), Certara UK, Certara UK Limited, Simcyp Division, Level 2-Acero, 1 Concourse Way, Sheffield, S1 2BJ, UK., Alam K; Division of Quantitative Methods and Modeling, Office of Research and Standards/OGD/CDER/FDA, Silver Spring, MD, United States of America., Tsakalozou E; Division of Quantitative Methods and Modeling, Office of Research and Standards/OGD/CDER/FDA, Silver Spring, MD, United States of America., Donnelly M; Division of Quantitative Methods and Modeling, Office of Research and Standards/OGD/CDER/FDA, Silver Spring, MD, United States of America., Feng K; Division of Quantitative Methods and Modeling, Office of Research and Standards/OGD/CDER/FDA, Silver Spring, MD, United States of America., Bois FY; Certara Predictive Technologies (CPT), Certara UK, Certara UK Limited, Simcyp Division, Level 2-Acero, 1 Concourse Way, Sheffield, S1 2BJ, UK.
Source: The AAPS journal [AAPS J] 2026 Apr 03; Vol. 28 (3). Date of Electronic Publication: 2026 Apr 03.
Publication Type: Journal Article
Journal Info: Publisher: American Association of Pharmaceutical Scientists Country of Publication: United States NLM ID: 101223209 Publication Model: Electronic Cited Medium: Internet ISSN: 1550-7416 (Electronic) Linking ISSN: 15507416 NLM ISO Abbreviation: AAPS J Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41927954
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Virtual Bioequivalence Assessment of Long-acting Injectable Suspensions Using PBPK Modeling: Part 1. Impact of particle Size on Formulation Variability.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Morris+NM%22">Morris NM</searchLink>; Certara Predictive Technologies (CPT), Certara UK, Certara UK Limited, Simcyp Division, Level 2-Acero, 1 Concourse Way, Sheffield, S1 2BJ, UK. Natalie.Morris@certara.com.<br /><searchLink fieldCode="AU" term="%22Djehizian+A%22">Djehizian A</searchLink>; Certara Predictive Technologies (CPT), Certara UK, Certara UK Limited, Simcyp Division, Level 2-Acero, 1 Concourse Way, Sheffield, S1 2BJ, UK.<br /><searchLink fieldCode="AU" term="%22Mittapelly+N%22">Mittapelly N</searchLink>; Certara Predictive Technologies (CPT), Certara UK, Certara UK Limited, Simcyp Division, Level 2-Acero, 1 Concourse Way, Sheffield, S1 2BJ, UK.<br /><searchLink fieldCode="AU" term="%22Telaprolu+KC%22">Telaprolu KC</searchLink>; Certara Predictive Technologies (CPT), Certara UK, Certara UK Limited, Simcyp Division, Level 2-Acero, 1 Concourse Way, Sheffield, S1 2BJ, UK.<br /><searchLink fieldCode="AU" term="%22Holland+BW%22">Holland BW</searchLink>; Certara Predictive Technologies (CPT), Certara UK, Certara UK Limited, Simcyp Division, Level 2-Acero, 1 Concourse Way, Sheffield, S1 2BJ, UK.<br /><searchLink fieldCode="AU" term="%22McNally+K%22">McNally K</searchLink>; Certara Predictive Technologies (CPT), Certara UK, Certara UK Limited, Simcyp Division, Level 2-Acero, 1 Concourse Way, Sheffield, S1 2BJ, UK.<br /><searchLink fieldCode="AU" term="%22Polak+S%22">Polak S</searchLink>; Certara Predictive Technologies (CPT), Certara UK, Certara UK Limited, Simcyp Division, Level 2-Acero, 1 Concourse Way, Sheffield, S1 2BJ, UK.; Jagiellonian University Medical College, Faculty of Pharmacy, Krakow, Poland.<br /><searchLink fieldCode="AU" term="%22Jamei+M%22">Jamei M</searchLink>; Certara Predictive Technologies (CPT), Certara UK, Certara UK Limited, Simcyp Division, Level 2-Acero, 1 Concourse Way, Sheffield, S1 2BJ, UK.<br /><searchLink fieldCode="AU" term="%22Alam+K%22">Alam K</searchLink>; Division of Quantitative Methods and Modeling, Office of Research and Standards/OGD/CDER/FDA, Silver Spring, MD, United States of America.<br /><searchLink fieldCode="AU" term="%22Tsakalozou+E%22">Tsakalozou E</searchLink>; Division of Quantitative Methods and Modeling, Office of Research and Standards/OGD/CDER/FDA, Silver Spring, MD, United States of America.<br /><searchLink fieldCode="AU" term="%22Donnelly+M%22">Donnelly M</searchLink>; Division of Quantitative Methods and Modeling, Office of Research and Standards/OGD/CDER/FDA, Silver Spring, MD, United States of America.<br /><searchLink fieldCode="AU" term="%22Feng+K%22">Feng K</searchLink>; Division of Quantitative Methods and Modeling, Office of Research and Standards/OGD/CDER/FDA, Silver Spring, MD, United States of America.<br /><searchLink fieldCode="AU" term="%22Bois+FY%22">Bois FY</searchLink>; Certara Predictive Technologies (CPT), Certara UK, Certara UK Limited, Simcyp Division, Level 2-Acero, 1 Concourse Way, Sheffield, S1 2BJ, UK.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101223209%22">The AAPS journal</searchLink> [AAPS J] 2026 Apr 03; Vol. 28 (3). <i>Date of Electronic Publication: </i>2026 Apr 03.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+of+Pharmaceutical+Scientists%22">American Association of Pharmaceutical Scientists </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101223209 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1550-7416 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215507416%22">15507416 </searchLink><i>NLM ISO Abbreviation: </i>AAPS J <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41927954
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1208/s12248-026-01213-2
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Virtual Bioequivalence Assessment of Long-acting Injectable Suspensions Using PBPK Modeling: Part 1. Impact of particle Size on Formulation Variability.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Morris NM
      – PersonEntity:
          Name:
            NameFull: Djehizian A
      – PersonEntity:
          Name:
            NameFull: Mittapelly N
      – PersonEntity:
          Name:
            NameFull: Telaprolu KC
      – PersonEntity:
          Name:
            NameFull: Holland BW
      – PersonEntity:
          Name:
            NameFull: McNally K
      – PersonEntity:
          Name:
            NameFull: Polak S
      – PersonEntity:
          Name:
            NameFull: Jamei M
      – PersonEntity:
          Name:
            NameFull: Alam K
      – PersonEntity:
          Name:
            NameFull: Tsakalozou E
      – PersonEntity:
          Name:
            NameFull: Donnelly M
      – PersonEntity:
          Name:
            NameFull: Feng K
      – PersonEntity:
          Name:
            NameFull: Bois FY
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 04
              Text: 2026 Apr 03
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1550-7416
          Numbering:
            – Type: volume
              Value: 28
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: The AAPS journal
              Type: main
ResultId 1